Matches in Nanopublications for { <http://rdf.disgenet.org/resource/nanopub/NP630814.RAnRHO6hZU64urw9tcUJF85QZKtuf4lZu7FO7XgzMyl3Q130_assertion> ?p ?o ?g. }
Showing items 1 to 6 of
6
with 100 items per page.
- NP630814.RAnRHO6hZU64urw9tcUJF85QZKtuf4lZu7FO7XgzMyl3Q130_assertion type Assertion NP630814.RAnRHO6hZU64urw9tcUJF85QZKtuf4lZu7FO7XgzMyl3Q130_head.
- NP630814.RAnRHO6hZU64urw9tcUJF85QZKtuf4lZu7FO7XgzMyl3Q130_assertion description "[In multivariate analysis of all patients and those with advanced disease, serum trypsin-2-API concentration was an adverse prognostic factor for cancer-specific and progression-free survival, and it was independent of stage and histological type of the tumor (P <or= 0.01).]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP630814.RAnRHO6hZU64urw9tcUJF85QZKtuf4lZu7FO7XgzMyl3Q130_provenance.
- NP630814.RAnRHO6hZU64urw9tcUJF85QZKtuf4lZu7FO7XgzMyl3Q130_assertion evidence source_evidence_literature NP630814.RAnRHO6hZU64urw9tcUJF85QZKtuf4lZu7FO7XgzMyl3Q130_provenance.
- NP630814.RAnRHO6hZU64urw9tcUJF85QZKtuf4lZu7FO7XgzMyl3Q130_assertion SIO_000772 15269150 NP630814.RAnRHO6hZU64urw9tcUJF85QZKtuf4lZu7FO7XgzMyl3Q130_provenance.
- NP630814.RAnRHO6hZU64urw9tcUJF85QZKtuf4lZu7FO7XgzMyl3Q130_assertion wasDerivedFrom befree-20150227 NP630814.RAnRHO6hZU64urw9tcUJF85QZKtuf4lZu7FO7XgzMyl3Q130_provenance.
- NP630814.RAnRHO6hZU64urw9tcUJF85QZKtuf4lZu7FO7XgzMyl3Q130_assertion wasGeneratedBy ECO_0000203 NP630814.RAnRHO6hZU64urw9tcUJF85QZKtuf4lZu7FO7XgzMyl3Q130_provenance.